Accessing this medication in the United States can be a major obstacle for some patients diagnosed with hereditary tyrosinemia type 1. Orphan drug status means a high price , hindering individual access https://aishazuul384987.mpeblog.com/75571889/nitisinone-in-the-usa-access-and-availability